(Date:12/4/2009)...ew findings by UT Southwestern researchers suggest...rders might also help slow the destruction of insu... with insulin-dependent (type 1) diabetes. , In...tes, cells in the pancreas called beta cells, whic...process. , Researchers at UT Southwestern and 14...
(Date:12/4/2009)...ender Corp., a leading manufacturer of over-the-co...d to enhance consumers’ quality of life, tod...American Podiatric Medical Association (APMA) Seal...ealthiFeet®. , (PRWE...ufacturer of over-the-counter topical cream and fi...
(Date:12/4/2009)...IS, Dec. 4 New data from the U.S. ...ruggled to get enough to eat at some point in 2008... six Americans struggled with hunger. To wake up A...n Powell, NBC,s The Biggest Loser,s Bob Harper and...a are teaming up to turn on the production line fo...
(Date:12/4/2009)... Dec. 4 PD-Rx Pharmaceut...venue of $5,012,334 for the first quarter ended Se...iod last year. Operating income and net income fo...ely, each a 70% decrease over the same period last...n pharmacy sector sales. This trend is expected t...
(Date:12/4/2009)...-- Substantial progress has been made over the las...o diagnose and treat epilepsy and its complication...ot reached most of the 50 million people around th...n people in the United States who have the disorde...sident of the American Epilepsy Society (AES), the...
Breaking Medicine News(10 mins):Health News:FDA-approved drug may slow beta cell destruction in type 1 diabetes patients 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 2Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 3Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 4Health News:PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4(Date:12/3/2009)..., SUNNYVALE, Calif., Dec. 3 /PRNewswire-FirstCall...armaceutical company focused on developing and com...he treatment of immune mediated diseases and cance... conference call on, Tuesday, December 8, 2009 at ...0am Pacific Time) to discuss clinical data regardi...
(Date:12/3/2009)... , HOERSHOLM, Denmark and SAN DIEGO, Ca...SPC3649 Successfully Inhibits miR-122, a microRNA ...by Significantly Reducing Hepatitis C,Virus in the...ith the,Hepatitis C Virus , - SPC3649 Dem...tance and,No Serious Adverse Events in the Treated...
(Date:12/3/2009)..., NASHVILLE, Tenn., Dec. 3 /PRNewswire-FirstCal...CPIX ) announced today that data from a recent cli...tion, an intravenous treatment for pain and fever,... Health-System Pharmacists (ASHP) Midyear Clinical... The new data will be displayed in a poster presen...
Breaking Medicine Technology:Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 2New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 3Improved Endo Capsule Software enhances diagnostic experience 10493 1Improved Endo Capsule Software enhances diagnostic experience 10493 2Cocoa in Chocolate May Be Good for the Heart 59974 1Cocoa in Chocolate May Be Good for the Heart 59974 2Cocoa in Chocolate May Be Good for the Heart 59974 3Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 59970 1Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 59970 2Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 59970 3...lizing,single-use bioprocessing for development an... today that it has completed a product fill under ... Trius Therapeutics Phase I,clinical trial., "We ...his GMP fill,project, an effort that we were able ...eadline," said Leigh N. Pierce, president of Pacif...
...ension,s Twenty-Third Annual...ercent (45%) of patients with stage 1, hypertensi...n medoxomil), and BENICAR HCT(R) (olmesartan med...ormotension (< 120/80 mm Hg) (placebo:1.4%)., ...tage 1 hypertension were, able to reach a goal blo...
Other Medicine Technology:PacificGMP Completes GMP Product Fill for Trius Therapeutics 2New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 2New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 3New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 4New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 5New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 6New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 7COULTER AcT diff2 (Recertified)
Perclose A-T Suture-Mediated Closure
Atria 3100 ECG
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: